Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1B hepatitis C patients from Serbia
Sign Up to like & getrecommendations! Published in 2023 at "Archives of Biological Sciences"
DOI: 10.2298/abs230316020k
Abstract: Variations in the hepatitis C virus (HCV) core sequence have been related to disease progression and response to antiviral therapy. Previously we showed that the methylation status of RASSF1A and p16 genes, and IL28B genotypes… read more here.
Keywords: response pegylated; genotype; therapy; hcv core ... See more keywords